via Indiana University School of Medicine
A silicone device that can change skin tissue into blood vessels and nerve cells has advanced from prototype to standardized fabrication, meaning it can now be made in a consistent, reproducible way. As reported in Nature Protocols, this work, developed by researchers at the Indiana University School of Medicine, takes the device one step closer to potential use as a treatment for people with a variety of health concerns.
The technology, called tissue nanotransfection, is a non-invasive nanochip device that can reprogram tissue function by applying a harmless electric spark to deliver specific genes in a fraction of a second. In laboratory studies, the device successfully converted skin tissue into blood vessels to repair a badly injured leg. The technology is currently being used to reprogram tissue for different kinds of therapies, such as repairing brain damage caused by stroke or preventing and reversing nerve damage caused by diabetes.
“This report on how to exactly produce these tissue nanotransfection chips will enable other researchers to participate in this new development in regenerative medicine,” said Chandan Sen, director of the Indiana Center for Regenerative Medicine and Engineering, associate vice president for research and Distinguished Professor at the IU School of Medicine.
Sen also leads the regenerative medicine and engineering scientific pillar of the IU Precision Health Initiative and is lead author on the new publication.
“This small silicone chip enables nanotechnology that can change the function of living body parts,” he said. “For example, if someone’s blood vessels were damaged because of a traffic accident and they need blood supply, we can’t rely on the pre-existing blood vessel anymore because that is crushed, but we can convert the skin tissue into blood vessels and rescue the limb at risk.”
In the Nature Protocols report, researchers published engineering details about how the chip is manufactured.
Sen said this manufacturing information will lead to further development of the chip in hopes that it will someday be used clinically in many settings around the world.
“This is about the engineering and manufacturing of the chip,” he said. “The chip’s nanofabrication process typically takes five to six days and, with the help of this report, can be achieved by anyone skilled in the art.”
Sen said he hopes to seek FDA approval for the chip within a year. Once it receives FDA approval, the device could be used for clinical research in people, including patients in hospitals, health centers and emergency rooms, as well as in other emergency situations by first responders or the military.
Original Article: Innovative silicone nanochip can reprogram biological tissue in living body
More from: Indiana University School of Medicine | University of Chicago
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Tissue nanotransfection
- Medical Topics News -- ScienceDaily
July 25, 2022 — Scientists have used state-of-the-art electron microscopy approaches to demonstrate that SARS-CoV-2 hijacks nanotubes, tiny bridges that link infected cells with neurons. The ...
- Tissue nanotransfection technology can serve as a non-viral, topical, gene-editing delivery device, research shows
Tissue nanotransfection technology can serve as a non-viral, topical, gene-editing delivery device, research shows Download PDF Copy Reviewed by Emily Henderson, B.Sc. Jul 19 2022 ...
- Tissue nanotransfection technology proves useful in non-viral topical gene editing to close complex cutaneous wounds
INDIANAPOLIS – The Indiana Center for Regenerative Medicine and Engineering (ICRME) at Indiana University School of Medicine is home to tissue nanotransfection (TNT) regenerative medicine ...
- Tissue nanotransfection technology proves useful in non-viral topical gene editing to close complex cutaneous wounds
TNT is a minimally invasive device that can reprogram tissue function in the live body by applying pulses of harmless, electric sparks to deliver specific genes of interest to the skin. "TNT-based ...
- Tissue nanotransfection technology proves useful in non-viral topical gene editing to close complex cutaneous wounds
New research demonstrates that tissue nanotransfection can serve as a non-viral, topical, gene-editing delivery device. The Indiana Center for Regenerative Medicine and Engineering (ICRME ...
Go deeper with Google Headlines on:
Tissue nanotransfection
Go deeper with Bing News on:
Tissue reprogramming
- Scientists create synthetic mouse embryos, a potential key to healing humans
Stem cell researchers in Israel have created synthetic mouse embryos without using a sperm or egg, then grown them in an artificial womb for eight days, a development that opens a window into a ...
- Enrichment of the Embryonic Stem Cell Reprogramming Factors Oct4, Nanog, Myc, and Sox2 in Benign and Malignant Vascular Tumors
Included in this study were 71 diseased vascular tissue samples originally collected from human patients, representing malignant (seven angiosarcomas, two hemangiopericytomas), borderline (six ...
- New Way to Reprogram Macrophages Helps Immune System Kill Tumors
In terms of cancer, macrophages, unlike T-cells, are able to penetrate solid tissue but are often a long way from being effective, ignoring diseased cells because the proteins on their outer layer ...
- Tissue nanotransfection technology can serve as a non-viral, topical, gene-editing delivery device, research shows
TNT is a minimally invasive device that can reprogram tissue function in the live body by applying pulses of harmless, electric sparks to deliver specific genes of interest to the skin.
- Induced Pluripotent Stem Cells Market Latest Trends, Size, Key Players, Revenue and Forecast 2028
Pluripotent stem cells are embryonic stem cells that can develop into any type of adult cell and aid in the healing of ...